Genetic Variation of Heart, Lung, and Kidney Disease in Sickle Cell Disease: Pre- and Post-Curative Therapies
| Short Name | HLKSCD
|
|---|---|
| Institution(s) |
Vanderbilt University
|
| Type of Omics | WGS
|
| Disease/Phenotype |
SCD in HLB
|
| Starting Phase | Phase 7
|
| TOPMed Accession # |
Please see this TOPMed Project's Parent Studies.
|
| Omics Center(s) Phase 7 |
Broad Institute Genomics Platform
|
| Phases Involved |
7
|
| Populations |
Adults and children from three SCD centers
|
| PI | |
| Co-PI | |
| NIH Program Officer | |
| Steering Committee Representatives | |
| P&P primary | |
| P&P alternate | |
| COL Contact(s) | |
| Project |
HLKSCD
|
Released
No
Back to top
